Noreen Parsons
Senior Strategic Advisor Commercial Strategy
Noreen is an experienced industry executive with 25+ years of leading teams in global , regional and local commercial strategy and transformation, pricing and market access, new product planning , portfolio strategy, go -to -market/launch excellence & life cycle management. She has also led an access to medicines consulting business and held board positions for joint ventures in the biosimilar space.
Noreen believes in innovative, dynamic , collaborative and expertise- based approach to optimizing opportunities and problem-solving. She has worked across multiple therapy areas throughout her career and most recently has enjoyed global leadership roles in oncology and immunology.
Her academic qualifications span science and business with a BSc in Pharmacy (Portsmouth) and a MSc in Marketing ( Manchester) and an MBA (Lancaster).
Latest news
Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report
Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient care LONDON, U.K, January 6, 2026 Clarivate Plc (NYSE: CLVT), a leading global provider…
Clarivate Library Innovation Awards Launch to Celebrate Global Library Excellence
Awards open to ELUNA, IGeLU and IUG members London, U.K. December 15, 2025: Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the inaugural…